Article Details

Zacks: Analysts Expect ChemoCentryx, Inc. (NASDAQ:CCXI) Will Post Quarterly Sales of $8.92 ...

Retrieved on: 2020-12-12 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Expect ChemoCentryx, Inc. (NASDAQ:CCXI) Will Post Quarterly Sales of $8.92 .... View article details on hiswai:

Excerpt

<b>BlackRock Inc</b>. now owns 4,472,434 shares of the biopharmaceutical company's stock valued at $245,087,000 after acquiring an additional 184,550 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo